NATCO Pharma

BSE : 524816 | NSE : NATCOPHARM
Industry : Pharmaceuticals | ISIN : INE987B01026 | FreeFloat : 46.20% | FnO : No | LotSize : N/A
Intellectual Capital (IC)763.31
Net Worth (NW)4,645.60
Intrinsic Worth (IW)5,408.91
Market Cap (MC)10,253.32
Economic Value Added-78.74
Discount Rate%
Liquidity Premium%
Knowledge Basis (IC/IW)14.11%
IC Gross Margin (EBITDA/IC)76.56%
IC Net Margin (NPT/IC)48.77%
Knowledge Turnover (Sales/IC)2.92
Market to Intrinsic Value (MC/IW)1.90
As OfIntrinsic ValueMarket Price
31 Dec 2022Rs. 296.29Rs. 561.65
20 Mar 2023 ---- Rs. 539.25
2.30     0.43%
Fundamental - medium termTechnical - near termCombined outlook
EVA > 0 : NoSell10 DMA : Rs. 547.19AccumulateSell on Rallies
KB > 50% : No50 DMA : Rs. 540.82
0 < M2IV < 1 : NoVol-Price trend : Rising
Disclaimer: Stock outlook is based on data calculations only and does NOT constitute investment advice.

Question 3 - Is this stock undervalued?

Question 2 - Does this business have significant knowledge assets?

Question 1 - Is this business generating enough profits to cover its cost of capital?

* EVA is a registered trademark of Stern Stewart and Co.
Quarterly Results (Rs. Cr)
Quarter
Type*
Sales
Income
EBITDA
EBIT
PBT
PAT
NPT
Mar-20
C
454.80
477.20
150.70
120.20
116.70
93.20
75.50
Jun-20
C
563.40
582.10
189.80
161.80
158.10
122.10
124.20
Sep-20
C
802.20
827.90
302.10
273.40
270.70
203.90
193.30
Dec-20
C
355.20
386.00
113.30
83.50
80.10
63.40
67.00
Mar-21
C
331.30
359.70
104.60
74.20
70.70
53.00
53.90
Jun-21
C
410.30
427.30
126.80
93.00
91.00
75.00
73.00
Sep-21
C
377.20
415.20
108.50
73.80
69.80
65.10
60.60
Dec-21
C
560.50
590.70
132.00
96.00
91.00
80.40
77.80
Mar-22
C
596.80
610.60
-4.80
-42.90
-49.60
-50.50
-32.10
Jun-22
C
884.60
918.90
429.60
390.00
385.80
320.40
329.10
Sep-22
C
432.10
452.60
115.80
74.10
70.30
56.80
53.70
Dec-22
C
492.50
513.30
126.70
85.20
81.40
62.30
74.30
* C - Consolidated, S - Standalone